Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu 30068, Taiwan.
Biomaterials. 2012 Sep;33(26):6172-85. doi: 10.1016/j.biomaterials.2012.05.009. Epub 2012 Jun 5.
Nanodiamond, a promising carbon nanomaterial, develops for biomedical applications such as cancer cell labeling and detection. Here, we establish the nanodiamond-bearing cancer cell lines using the fluorescent and magnetic nanodiamond (FMND). Treatment with FMND particles did not significantly induce cytotoxicity and growth inhibition in HFL-1 normal lung fibroblasts and A549 lung cancer cells. The fluorescence intensities and particle complexities were increased in a time- and concentration-dependent manner by treatment with FMND particles in lung cancer cells; however, the existence of FMND particles inside the cells did not alter cellular size distribution. The FMND-bearing lung cancer cells could be separated by the fluorescent and magnetic properties of FMNDs using the flow cytometer and magnetic device, respectively. The FMND-bearing cancer cells were identified by the existence of FMNDs using flow cytometer and confocal microscope analysis. More importantly, the cell morphology, viability, growth ability and total protein expression profiles in the FMND-bearing cells were similar to those of the parental cells. The separated FMND-bearing cells with various generations were cryopreservation for further applications. After re-thawing the FMND-bearing cancer cell lines, the cells still retained the cell survival and growth ability. Additionally, a variety of human cancer types including colon (RKO), breast (MCF-7), cervical (HeLa), and bladder (BFTC905) cancer cells could be used the same strategy to prepare the FMND-bearing cancer cells. These results show that the FMND-bearing cancer cell lines, which reserve the parental cell functions, can be applied for specific cancer cell labeling and tracking.
纳米金刚石是一种很有前途的碳纳米材料,可应用于癌症细胞标记和检测等生物医学领域。在此,我们使用荧光和磁性纳米金刚石(FMND)建立了含有纳米金刚石的癌细胞系。FMND 颗粒处理不会显著诱导 HFL-1 正常肺成纤维细胞和 A549 肺癌细胞的细胞毒性和生长抑制。肺癌细胞中 FMND 颗粒处理会以时间和浓度依赖的方式增加荧光强度和颗粒复杂性;然而,FMND 颗粒在细胞内的存在不会改变细胞大小分布。FMND 标记的肺癌细胞可以分别通过流式细胞仪和磁性装置的荧光和磁性特性进行分离。通过流式细胞仪和共聚焦显微镜分析,证实了含有 FMND 的癌细胞的存在。更重要的是,FMND 标记的细胞形态、活力、生长能力和总蛋白表达谱与亲本细胞相似。经过各种传代的分离的 FMND 标记细胞被冷冻保存,以备进一步应用。在重新解冻 FMND 标记的癌细胞系后,细胞仍然保留了细胞存活和生长能力。此外,还可以使用相同的策略来制备含有 FMND 的各种人类癌症类型的癌细胞,包括结肠(RKO)、乳腺(MCF-7)、宫颈(HeLa)和膀胱(BFTC905)癌细胞。这些结果表明,保留亲本细胞功能的含有 FMND 的癌细胞系可用于特定的癌细胞标记和跟踪。